Jillian Theobald, MD, PhD
Associate Professor; Associate Medical Director, Wisconsin Poison Center
Contact Information
Education
BA, Carthage College, Kenosha, WI 2001
Biography
Jillian Theobald, MD PhD, received a bachelor's of arts from Carthage College where she majored in physics and minored in math and biology. In 2008 she obtained her Doctorate in Cell Biology and Anatomy exploring the intrinsic regulation of gene expression in developmental biology, specifically myogenesis, and in 2010 her medical degree from Rosalind Franklin University of Medicine and Science. She went on to an emergency medicine residency at University of Illinois Hospital and Health Sciences System ending in 2013. Subsequently, she completed a medical toxicology fellowship at the Toxikon Consortium (Cook County Hospital, Illinois Poison Center and University of Illinois Hospital) in Chicago. Dr. Theobald has authored multiple chapters in Emergency Medicine textbooks and continues to engage in research that explores the validity of historical management paradigms of toxicological exposures, determines the variables surrounding opioid overdose deaths, and assesses the quality improvement processes of poison center operations.
She is the Quality Assurance director at the Wisconsin Poison Center and has implemented multiple quality improvement projects aimed at improving accuracy and care delivery. Dr. Theobald is also the Co-Medical Director of the Adult Translational Research Unit at the Clinical & Translational Science Institute of Southwest Wisconsin. The Adult Translational Research Unit provides infrastructural support for clinical and translational research projects by providing access to space, resources and the expertise of research support personnel.
Honors and Awards
2014 - Best Fellow-In-Training Research Symposium Award
2015 - Outstanding Poster Award North American Congress of Clinical Toxicology
2017 - MCW Outstanding Medical Student Teacher
2018 - MCW Dept. of Emergency Medicine Outstanding Off-Service Clinical Faculty
Research Interests
Publications
-
Utility of iron concentration two to four hours post ingestion in predicting toxicity
(Fox H, Jansen A, Theobald J, Stanton M, Feldman R.) American Journal of Emergency Medicine. January 2025;87:70-73 SCOPUS ID: 2-s2.0-85208142108 01/01/2025
-
(Feldman R, Theobald J, Stanton M, Stolbach A, Tormoehlen L.) Neurology. 2024 May 14;102(9):e209363 PMID: 38648601 SCOPUS ID: 2-s2.0-85191498478 04/23/2024
-
(Feldman R, Stanton M, Corcoran J, Bialkowski K, Theobald J, Gummin D.) Clin Toxicol (Phila). 2024 Mar;62(3):207-209 PMID: 38525877 SCOPUS ID: 2-s2.0-85188549470 03/25/2024
-
(Theobald JL, Corcoran JN.) Nelson Textbook of Pediatrics: Volume 1-2. 1 January 2024:700-725.e2 SCOPUS ID: 2-s2.0-85206228460 01/01/2024
-
(Feldman R, Autry B, Dukes J, Lofy T, Marchetti G, Patt A, Batterman N, Theobald J.) Clin Toxicol (Phila). 2023 Nov;61(11):941-951 PMID: 38112312 SCOPUS ID: 2-s2.0-85180420727 12/19/2023
-
Incidence of rebound salicylate toxicity following cessation of urine alkalinization.
(O'Keefe M, Stanton M, Feldman R, Theobald J.) Clin Toxicol (Phila). 2023 Jul;61(7):536-542 PMID: 37427892 SCOPUS ID: 2-s2.0-85164747657 07/10/2023
-
Seizure Occurring During Baclofen Monotherapy for Phenibut Withdrawal.
(Patt A, Fox H, Wells L, Theobald J, Feldman R.) Clin Neuropharmacol. 2023 Mar-Apr 01;46(2):79-81 PMID: 36735548 SCOPUS ID: 2-s2.0-85150170759 02/04/2023
-
Outcomes of pediatric ingestions of alcohol-based hand sanitizers during the COVID-19 pandemic
(Corcoran J, Feldman R, Theobald J.) Clinical Toxicology. 2023;61(8):613-615 SCOPUS ID: 2-s2.0-85171690214 01/01/2023
-
(Ryan K, Benz P, Zosel A, Farkas A, Theobald J.) Cardiovasc Toxicol. 2022 Sep;22(9):866-877 PMID: 35930218 SCOPUS ID: 2-s2.0-85135527018 08/06/2022
-
(Maso K, Theobald JL.) AEM Educ Train. 2022 Apr;6(2):e10727 PMID: 35368502 PMCID: PMC8908305 04/05/2022
-
Hemolysis after subcutaneous deoxycholic acid overdose.
(Sharpe A, O'Keefe M, Windsor K, Theobald J, Feldman R.) Am J Emerg Med. 2022 Feb;52:268.e1-268.e2 PMID: 34456101 SCOPUS ID: 2-s2.0-85113786357 08/31/2021
-
(MacKinnon GE 3rd, Theobald J, Seckel E, MacKinnon KJ, Lamberton N, Velazquez DV.) J Am Pharm Assoc (2003). 2021;61(4):e249-e254 PMID: 33773933 SCOPUS ID: 2-s2.0-85103113179 03/29/2021